Compare BMY & COP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BMY | COP |
|---|---|---|
| Founded | 1887 | 1917 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Integrated oil Companies |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 95.0B | 109.6B |
| IPO Year | N/A | N/A |
| Metric | BMY | COP |
|---|---|---|
| Price | $50.82 | $93.21 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 12 | 18 |
| Target Price | $55.58 | ★ $114.94 |
| AVG Volume (30 Days) | ★ 15.1M | 6.6M |
| Earning Date | 10-30-2025 | 11-06-2025 |
| Dividend Yield | ★ 4.80% | 3.62% |
| EPS Growth | ★ N/A | N/A |
| EPS | 2.97 | ★ 7.08 |
| Revenue | $48,034,000,000.00 | ★ $61,280,000,000.00 |
| Revenue This Year | $0.23 | $10.27 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $17.39 | ★ $13.13 |
| Revenue Growth | 1.26 | ★ 7.65 |
| 52 Week Low | $42.52 | $79.88 |
| 52 Week High | $63.33 | $106.20 |
| Indicator | BMY | COP |
|---|---|---|
| Relative Strength Index (RSI) | 63.47 | 60.99 |
| Support Level | $48.22 | $88.58 |
| Resistance Level | $52.51 | $95.07 |
| Average True Range (ATR) | 1.13 | 1.94 |
| MACD | 0.29 | 0.64 |
| Stochastic Oscillator | 77.92 | 78.76 |
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
ConocoPhillips is a US-based independent exploration and production firm. Its operations are primarily in Alaska and the Lower 48, with footprints in Canada, Europe, Asia-Pacific, the Middle East, and Africa. It also has substantial integrated LNG production and marketing activities across geographies.